    <SEC-DOCUMENT>0001308179-23-000065-index.html : 20230227
    <SEC-HEADER>0001308179-23-000065.hdr.sgml : 20230227
    <ACCEPTANCE-DATETIME>20230227080033
    ACCESSION NUMBER:		0001308179-23-000065
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230227
    DATE AS OF CHANGE:		20230227
    EFFECTIVENESS DATE:		20230227

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Moderna, Inc.
    		CENTRAL INDEX KEY:			0001682852
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		IRS NUMBER:				813467528
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38753
    		FILM NUMBER:		23670094

    	BUSINESS ADDRESS:
    		STREET 1:		200 TECHNOLOGY SQUARE
    		CITY:			CAMBRIDGE
    		STATE:			MA
    		ZIP:			02139
    		BUSINESS PHONE:		6177146500

    	MAIL ADDRESS:
    		STREET 1:		200 TECHNOLOGY SQUARE
    		CITY:			CAMBRIDGE
    		STATE:			MA
    		ZIP:			02139

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Moderna Therapeutics, Inc.
    		DATE OF NAME CHANGE:	20160822
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>lmrna2023_ars.pdf
    <DESCRIPTION>MODERNA, INC. - ARS
    <TEXT>
    Document 1 - file: lmrna2023_ars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>